Treatment of B-cell Acute Lymphoblastic Leukaemia has improved thanks to CAR-T therapies, but relapse is still very common.

Our immune system works to fight infections immediately, but also maintain long-term immunity. Two waves of protection help ...

Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipelineDren Bio deep B-cell ...

Treatment of B-cell Acute Lymphoblastic Leukaemia has been greatly improved by CAR-T therapies, but relapse is still very common. An international team has now found in animal models a new approach ...

Cancer is the rapid proliferation of malignant cells that permeate tissue and cause dysregulation of the body’s daily functions. Many cancers can be characterized by the mutation cells have and how ...

“Understanding how the repertoire of immune cells fits with the diverse landscape of brain cancer types can help us find new ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most ...

Dren Bio deep B-cell depleter program has the potential to reset the immune system Acquisition underpins path for Sanofi becoming leading immunology ... the treatment of cancer, autoimmune ...